Clinical Trials Browser

Unknown × Cholangiocarcinoma × regorafenib × Clear all

NCT05535647 2022-09-10

Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma